Homologous recombination repair deficiency (HRD): From biology to clinical exploitation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Homologous recombination repair deficiency (HRD): From biology to clinical exploitation

Published:2021-02-10 Issue:5 Volume:60 Page:299-302
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Gonzalez David¹,Stenzinger Albrecht²³⁴^ORCID

Affiliation:

1. Patrick G Johnston Centre for Cancer Research Queens University Belfast Belfast UK

2. Institute of Pathology University Hospital Heidelberg Heidelberg Germany

3. German Cancer Consortium (DKTK) Heidelberg Germany

4. German Center for Lung Research (DZL) Heidelberg Germany

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.22939

Reference40 articles.

1. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

2. Prevalence of homologous recombination‐related gene mutations across multiple cancer types;Heeke AL;JCO Precis Oncol,2018

3. Non-homologous DNA end joining and alternative pathways to double-strand break repair

4. PARP inhibitors: Synthetic lethality in the clinic

5. Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches;Frontiers in Oncology;2024-08-16

2. Multiomics analysis of homologous recombination deficiency across cancer types;Biomolecules and Biomedicine;2024-07-28

3. 1G6‐D7 Inhibits Homologous Recombination Repair by Targeting Extracellular HSP90α to Promote Apoptosis in Non–Small Cell Lung Cancer;Environmental Toxicology;2024-06-20

4. Concordance between an FDA-approved companion diagnostic and an alternative assay kit for assessing homologous recombination deficiency in ovarian cancer;Gynecologic Oncology;2024-05

5. Combining Homologous Recombination-Deficient Testing and Functional RAD51 Analysis Enhances the Prediction of Poly(ADP-Ribose) Polymerase Inhibitor Sensitivity;JCO Precision Oncology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3